Bioavailability of everolimus administered as a single 5 mg tablet versus five 1 mg tablets: a randomized, open-label, two-way crossover study of healthy volunteers
Karen Thudium,1 Jorge Gallo,2 Emmanuel Bouillaud,2 Carolin Sachs,2 Simantini Eddy,1 Wing Cheung1 1Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA; 2Novartis Pharma AG, Basel, Switzerland Background: The mammalian target of rapamycin (mTOR) inhibitor everolimus has a well-established phar...
Saved in:
Main Authors: | Thudium K (Author), Gallo J (Author), Bouillaud E (Author), Sachs C (Author), Eddy S (Author), Cheung W (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2015-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bioequivalence of generic alendronate sodium tablets (70 mg) to Fosamax® tablets (70 mg) in fasting, healthy volunteers: a randomized, open-label, three-way, reference-replicated crossover study
by: Zhang Y, et al.
Published: (2017) -
Bioavailability of three novel oral, sustained‐release pellets, relative to an immediate‐release tablet containing 500 mg flucytosine: A randomized, open‐label, crossover study in healthy volunteers
by: Vishal Goyal, et al.
Published: (2024) -
Study of the effect of food on the bioavailability, safety and tolerability of Aterixen<sup>®</sup> 100 mg tablet in healthy volunteers
by: V. B. Vasilyuk, et al.
Published: (2023) -
Bioequivalence study of a new sildenafil 100 mg orodispersible film compared to the conventional film-coated 100 mg tablet administered to healthy male volunteers
by: Radicioni M, et al.
Published: (2017) -
Bioequivalence Study of 100-mg Cilostazol Tablets in Healthy Thai Adult Volunteers
by: Somruedee Chatsiricharoenkul, MD, et al.
Published: (2019)